Maternal nutrient intake and fetal growth

Intake of folate, vitamin B12, and iron is not linked to fetal abdominal circumference or estimated fetal weight growth, placental weight, or birth weight, according to recent findings. However, lower maternal concentrations of hemoglobin were connected to faster fetal growth rates and larger placental weights and larger birthweights.¹

Takeaways

The study found no significant links between the intake of folate, vitamin B12, and iron during pregnancy and fetal abdominal circumference, estimated fetal weight growth, placental weight, or birth weight.
Lower maternal concentrations of hemoglobin were associated with faster fetal growth rates, larger placental weights, and higher birth weights. This suggests a connection between maternal hemoglobin levels and neonatal outcomes.
Folate and vitamin B12 deficiencies were previously linked to megaloblastic anemia and pernicious anemia, respectively, both of which were connected to lower birth weight among infants.
The study involved 759 mother-child pairs recruited from the ROLO study, a Randomised cOntrol trial of LOw glycaemic index diet in pregnancy, conducted at the National Maternity Hospital in Dublin between 2007 to 2011. Eligible participants were secundigravida women over 18 years with a singleton pregnancy ≤18 weeks' gestation.
The researchers developed growth trajectory models based on abdominal circumference and estimated fetal weight, revealing a negative association between lower maternal hemoglobin concentrations at 28 weeks' gestation and greater rates of fetal growth, higher birth weights, and higher placental weights.

These findings were drawn from a secondary analysis expanding upon existing research on associations of maternal nutrient intake at the time of pregnancy. This research was led by David J. Rooney, from the University College Dublin National Maternity Hospital’s UCD Perinatal Research Centre in Ireland.

Rooney and colleagues noted that folate and vitamin B12 deficiencies had previously been linked to megaloblastic anemia and pernicious anemia, respectively, with both connected to lower birthweight among infants.²

“Our primary aim was to assess differences between maternal dietary micronutrient intakes (iron, folate and vitamin B12), and maternal full blood count (FBC) parameters, according to fetal abdominal circumference (AC) and estimated fetal weight (EFW) growth trajectory classes,” Rooney and colleagues wrote.

As a secondary aim, the investigators sought to evaluate links between maternal hemoglobin, maternal dietary micronutrient intakes (such as folate, iron, and vitamin B12), with placental weight and with birthweight.

Background and Findings

The investigators’ secondary analysis involved the recruitment of 759 mother-child pairs from the Randomised cOntrol trial of LOw glycaemic index diet in pregnancy with the goal of preventing macrosomia (ROLO study). The research was carried out at the National Maternity Hospital in Dublin between 2007 - 2011.

Those who were eligible were secundigravida women in the age range of >18 years and had a singleton pregnancy ≤18 weeks' gestation, as well as having delivered an infant >4 kg previously in their initial pregnancy. Criteria for exclusion from the study included having regular medications, the existence of known medical disorders, or having current/past gestational diabetes.

The research team randomly assigned participants to the intervention arm (low glycemic index dietary advice) or to the control arm (routine antenatal care). The team looked into maternal parameters, assessments of diet, blood samples, and fetal ultrasound measurements at several different stages. ROLO study results were previously published.

The investigators’ new analysis developed growth trajectory models designed to look at abdominal circumference and estimated fetal weight through the use of latent class modeling based on measurements done at 20 and 34 weeks' gestation, as well as birth measurements. The team had subjects self-report smoking status and intake of supplements, with nutritional supplement types not being specified in participants’ dietary assessments.

Participants’ intake of both iron and folate at the time of each trimester was shown by the investigators to have been inadequate, but they noted that levels of maternal hemoglobin were sufficient at the 13- and 28-week points during gestation. Placental weight, fetal growth trajectories, and birthweights were also shown not to have any links with dietary consumption of folate, iron, and vitamin B12.

Despite these findings, the team did note that lower maternal hemoglobin concentrations at Week 28 week's period of gestation were associated with greater rates of fetal growth, higher birth weights, and higher placental weights.

The research team hypothesized that fetuses undergoing rapid growth may require greater levels of oxygen and hemoglobin, perhaps resulting in a decline in maternal hemoglobin levels in late pregnancy. Their findings suggest a negative association between hemoglobin levels and neonatal birth weights at 28 weeks' gestation, giving credence to their postulation.

“These findings may be due to biochemical responses in the placenta to lower oxygen states, physiological protective expansions in plasma volume later in pregnancy and potentially greater consumption of maternal iron and hemoglobin by fetuses on accelerated growth trajectories,” they wrote.